tirzepatide in europe Switch to T2D More Effective Than Upping Dulaglutide Dose GLP-1 boom causing pharma players

And the big moment for me, the reason Im finally able to have this conversation outside of our very small world of integrative functional root cause, you know, lifestyle medicine is that we have a GLP one agonist and what a GLP one agonist has done because it is a biosimilar hormone replacement is its actually teaching people about our weight, health hormones

Peschel D, Koerting R, Nass N

Blood sugar regulation changes on GLP-1 therapy as well

Physician 43, 4651

Here, we propose a reinforced mode of the gutbone axis plus X that the gutbone axis synergizes with other tissues or organs in the form of additive effects on clinical manifestations and mechanisms of action that are in tandem, constructing a broader biological network at the core of the gutbone axis while spreading to other systems of the organism

Psychiatry 42 , 349358 (1997)